MiR-106a targets Mcl-1 to suppress cisplatin resistance of ovarian cancer A2780 cells
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MiR-106a targets Mcl-1 to suppress cisplatin resistance of ovarian cancer A2780 cells
Authors
Keywords
miR-106a, ovarian cancer, cisplatin resistance, Mcl-1
Journal
Journal of Huazhong University of Science and Technology-Medical Sciences
Volume 33, Issue 4, Pages 567-572
Publisher
Springer Nature
Online
2013-07-31
DOI
10.1007/s11596-013-1160-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Platinum compounds sensitize ovarian carcinoma cells to ABT-737 by modulation of the Mcl-1/Noxa axis
- (2013) Karin Simonin et al. APOPTOSIS
- MiR-106a is an independent prognostic marker in patients with glioblastoma
- (2013) Shiguang Zhao et al. NEURO-ONCOLOGY
- Growth-Promoting Role of the miR-106a∼363 Cluster in Ewing Sarcoma
- (2013) Layne Dylla et al. PLoS One
- Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer
- (2012) Kristina Schee et al. BMC CANCER
- Evolving concepts in the management of drug resistant ovarian cancer: Dose dense chemotherapy and the reversal of clinical platinum resistance
- (2012) David J. Pinato et al. CANCER TREATMENT REVIEWS
- miR-106a overexpression and pRB downregulation in sporadic colorectal cancer
- (2012) T. Catela Ivkovic et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells
- (2012) Weiwei Cheng et al. FEBS Journal
- Inhibitory effects of microRNA-34a on cell migration and invasion of invasive urothelial bladder carcinoma by targeting notch1
- (2012) Chao Zhang et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- miR-106a is frequently upregulated in gastric cancer and inhibits the extrinsic apoptotic pathway by targeting FAS
- (2012) Zaozao Wang et al. MOLECULAR CARCINOGENESIS
- Determination of Reference microRNAs for Relative Quantification in Porcine Tissues
- (2012) Oriol Timoneda et al. PLoS One
- microRNAs as novel epigenetic biomarkers for human cancer
- (2011) María Cortés-Sempere et al. Clinical & Translational Oncology
- miR-125b confers resistance of ovarian cancer cells to cisplatin by targeting pro-apoptotic Bcl-2 antagonist killer 1
- (2011) Fanfei Kong et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- Unknown
- (2011) Zhu Yuan et al. MOLECULAR MEDICINE
- Cytoplasmic p21 expression levels determine cisplatin resistance in human testicular cancer
- (2010) Roelof Koster et al. JOURNAL OF CLINICAL INVESTIGATION
- Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients
- (2009) Ram Eitan et al. GYNECOLOGIC ONCOLOGY
- Mcl-1 is an important determinant of the apoptotic response to the BH3-mimetic molecule HA14-1 in cisplatin-resistant ovarian carcinoma cells
- (2009) K. Simonin et al. MOLECULAR CANCER THERAPEUTICS
- MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents
- (2009) D. R. Cochrane et al. MOLECULAR CANCER THERAPEUTICS
- MicroRNA Microarray Identifies Let-7i as a Novel Biomarker and Therapeutic Target in Human Epithelial Ovarian Cancer
- (2008) N. Yang et al. CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now